CSIMarket


Arcturus Therapeutics Holdings Inc   (ARCT)
Other Ticker:  
 

Arcturus Therapeutics Holdings Inc

ARCT's Fundamental analysis








Looking into Arcturus Therapeutics Holdings Inc growth rates, revenue grew by 237.65 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 114

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.74 %

Arcturus Therapeutics Holdings Inc net loss deacreased by in III. Quarter 2023 year on year, Arcturus Therapeutics Holdings Inc net loss increased by -54 % in III. Quarter 2023 year on year,

More on ARCT's Growth


Arcturus Therapeutics Holdings Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Arcturus Therapeutics Holdings Inc PEG ratio is at -0.07 Company is currently trading with Price to Cash flow multiple of 7.47 in trailing twelve-month period.
Company
11.02
PE TTM   
Industry
2027.12
PE TTM    
Company's Price to Sales ratio is at 3.26.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.81.


More on ARCT's Valuation
 
 Total Debt (Millions $) 20
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 2,428,172
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 8.7
 Tangible Book Value (Per Share $) 10.53

Arcturus Therapeutics Holdings Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Arcturus Therapeutics Holdings Inc PEG ratio is at -0.07 Company is currently trading with Price to Cash flow multiple of 7.47 in trailing twelve-month period.
Company
11.02
PE TTM   
Industry
2027.12
PE TTM    
Company's Price to Sales ratio is at 3.26.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.81.

Arcturus Therapeutics Holdings Inc Price to Book Ratio is at 3.45 lower than Indusry Avg. of 1298.49. and higher than S&P 500 Avg. of -1999.75

More on ARCT's Valuation

  Market Capitalization (Millions $) 966
  Shares Outstanding (Millions) 27
  Employees 122
  Revenues (TTM) (Millions $) 296
  Net Income (TTM) (Millions $) 99
  Cash Flow (TTM) (Millions $) 129
  Capital Exp. (TTM) (Millions $) -6
  Total Debt (Millions $) 20
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 2,428,172
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 8.7
  Tangible Book Value (Per Share $) 10.53

  Market Capitalization (Millions $) 966
  Shares Outstanding (Millions) 27
  Employees 122
  Revenues (TTM) (Millions $) 296
  Net Income (TTM) (Millions $) 99
  Cash Flow (TTM) (Millions $) 129
  Capital Exp. (TTM) (Millions $) -6





  Ratio
   Capital Ratio (MRQ) 4.49
  Total Debt to Equity (MRQ) 0.07
  Tangible Leverage Ratio (MRQ) 0.54
  Asset Turnover Ratio (TTM) 0.72
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com